Surgery Partners, Inc. (SGRY) News
Filter SGRY News Items
SGRY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SGRY News Highlights
- SGRY's 30 day story count now stands at 5.
- Over the past 16 days, the trend for SGRY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about SGRY are LOAN, DEC and PAR.
Latest SGRY News From Around the Web
Below are the latest news stories about SURGERY PARTNERS INC that investors may wish to consider to help them evaluate SGRY as an investment opportunity.
Insider Sell: Exec Chairman Wayne Deveydt Sells 168,130 Shares of Surgery Partners Inc (SGRY)Wayne Deveydt, the Executive Chairman of the Board of Surgery Partners Inc (NASDAQ:SGRY), has executed a significant stock sale according to a recent SEC filing. |
Surgery Partners, Inc. Announces Proposed Secondary Offering of Common StockBRENTWOOD, Tenn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners” or the “Company”) today announced that certain of the Company’s stockholders (the “Selling Stockholders”) intend to offer for sale in an underwritten secondary offering (the “Offering”) 8,000,000 shares of the Company’s common stock, par value $0.01 per share. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be c |
Here’s Why Surgery Partners (SGRY) Declined in Q3ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Rising bond rates and the Federal Reserve’s shift to a more hawkish stance put pressure on stocks in the third quarter. The strategy underperformed its Russell 3000 Index in the third […] |
Does Insulet (PODD) Face Challenges from the New Weight Loss Drug?ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Rising bond rates and the Federal Reserve’s shift to a more hawkish stance put pressure on stocks in the third quarter. The strategy underperformed its Russell 3000 Index in the third […] |
Surgery Partners, Inc. Completes Refinancing TransactionBRENTWOOD, Tenn., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company, has received commitments for a new $1.4 billion senior secured term loan (the “New Term Loan”). Upon closing (such date, the “Closing Date”), the new Term Loan will bear interest at a rate equal to 3.50% per annum in ex |
A Look At The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)Key Insights Surgery Partners' estimated fair value is US$25.76 based on 2 Stage Free Cash Flow to Equity With US$25.62... |
Surgery Partners, Inc. (NASDAQ:SGRY) Q3 2023 Earnings Call TranscriptSurgery Partners, Inc. (NASDAQ:SGRY) Q3 2023 Earnings Call Transcript November 7, 2023 Surgery Partners, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.14. Operator: Good morning, ladies and gentlemen, and welcome to Surgery Partners’ Third Quarter of 2023 Earnings Call. Currently, all participants are in listen-only mode. A question-and-answer session will follow the […] |
Compared to Estimates, Surgery Partners (SGRY) Q3 Earnings: A Look at Key MetricsThe headline numbers for Surgery Partners (SGRY) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
Surgery Partners Inc (SGRY) Reports 8.6% Revenue Growth in Q3 2023Adjusted EBITDA Rises by 9.7%, Full Year Guidance Raised |
Surgery Partners, Inc. Announces Third Quarter 2023 ResultsBRENTWOOD, Tenn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. Revenues were $674.1 million representing 8.6% growth Days Adjusted Same-facility revenues increased 14.2% Net loss attributable to Surgery Partners was $4.9 million Adjusted EBITDA was $105.5 million, representing 9.7% growthAdjusted EBITDA margi |